Invivyd Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	53.01	49.13	47.04	36.52
Research & Development	162.62	158.66	179.21	182.89
Other Operating Expenses	4.15	4.98	4.4	7.5
Operating Expenses	219.78	212.76	230.66	226.91
Operating Income	-219.78	-212.76	-230.66	-226.91
Other Expense / Income	-12.96	-14.12	10.66	-0.12
Pretax Income	-206.82	-198.64	-241.32	-226.79
Net Income	-206.82	-198.64	-241.32	-226.79
Shares Outstanding (Basic)	116	110	108	43
Shares Outstanding (Diluted)	116	110	108	43
Shares Change	6.28%	1.16%	154.02%	-
EPS (Basic)	-1.87	-1.81	-2.23	-5.32
EPS (Diluted)	-1.87	-1.81	-2.23	-5.32
Free Cash Flow	-182.33	-173.78	-221.69	-184.82
Free Cash Flow Per Share	-1.58	-1.59	-2.05	-4.34
EBITDA	-204.77	-196.62	-240.86	-226.79
Depreciation & Amortization	2.05	2.03	0.46	0
EBIT	-206.82	-198.64	-241.32	-226.79

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).